← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 15, 2021Last known activity
Aug 15, 2025
Timeline
2010s
- Jun 1, 2018
MapLight Therapeutics— Founded
Drugs by trial phase (2 distinct, 4 trials)
Phase 2 (2 own, 0 via acquisition)
Recent trials (6)
- NCT06887192Lead sponsorPhase 2Aug 15, 2025
- NCT06887192OfficialPhase 2Aug 15, 2025
- NCT07038876Lead sponsorPhase 2Jun 27, 2025
- NCT07038876OfficialPhase 2Jun 27, 2025
- NCT05889273Lead sponsorPhase 2Jun 15, 2023
- NCT05081245Lead sponsorPhase 2Nov 15, 2021
Details
- Founded
- San Francisco, CA, US Jun 1, 2018
- Last known activity
- Aug 15, 2025